Respiratory virus vaccines are used to prevent viruses from harming the human body. There are a variety of vaccines against pancreatitis, rubella, measles, influenza, coronavirus and other viruses. The components of the vaccine are also differentiated according to age.
This report contains market size and forecasts of Respiratory Virus Vaccines in global, including the following market information:
Global Respiratory Virus Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Respiratory Virus Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Respiratory Virus Vaccines companies in 2021 (%)
The global Respiratory Virus Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Inactivated Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Respiratory Virus Vaccines include CSL Limited, Sanofi, AstraZeneca, Merck & Co., Inc., GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Bharat Biotech and Sinovac Biotech Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Respiratory Virus Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Virus Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Respiratory Virus Vaccines Market Segment Percentages, by Type, 2021 (%)
Inactivated Vaccines
Live-attenuated Vaccines
Recombinant Vaccines
Global Respiratory Virus Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Respiratory Virus Vaccines Market Segment Percentages, by Application, 2021 (%)
Physician's Office
Hospitals
Clinics
Pharmacies/Stores
Global Respiratory Virus Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Respiratory Virus Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Respiratory Virus Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Respiratory Virus Vaccines revenues share in global market, 2021 (%)
Key companies Respiratory Virus Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Respiratory Virus Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
CSL Limited
Sanofi
AstraZeneca
Merck & Co., Inc.
GlaxoSmithKline plc
Serum Institute of India Pvt. Ltd.
Bharat Biotech
Sinovac Biotech Ltd.